Insights from 2023 ASH Annual Meeting
A

Treatment Strategies for Hematocrit Control in PV

By Insights from 2023 ASH Annual Meeting FEATURING Amy Zhou
By Insights from 2023 ASH Annual Meeting FEATURING Amy Zhou
0 views
January 8, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

24:35
Indy Hematology Review

Current Approaches in the Treatment of Myeloproliferative Neoplasms

Feat. A. Tefferi

Featured Video

24:08
Indy Hematology Review

Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…

Feat. A. Tefferi

Recommended

AUTOPLAY
24:08
Indy Hematology Review

Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…

Feat. A. Tefferi
27:47
Indy Hematology Review

Current Advances in the Treatment of Aggressive B- and T-Cell Lympho…

Feat. S. Smith
24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray
16:18
Masterclasses in Dermatology

Masterclasses from the Wards

Feat. S. Elman
23:35
University of Colorado Division of Hematology

2024 Updates in PV/ET

Feat. B. McMahon
24:27
BMFcases

Experts Discuss Pros and Cons of Treatment Approaches in PV

Feat. T. Bat, A. Tefferi
27:37
Indy Hematology Review

Review of Myeloproliferative Neoplasms

Feat. A. Tefferi
06:00
2024 Clinical Case Studies

Clinical Case Review: A Not-So-Sweet Case of Vulvar Ulceration

Feat. A. Geisler
17:05
BMFcases

Diagnosis and Prognosis in PV: Utility of BM Biopsy, Clinical Findin…

Feat. T. Bat, A. Tefferi
17:07
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Comparative Review of Toxicities and Their…

Feat. M. Minnema
31:12
UChicago Medicine

Practice-Changing Abstracts in NHL and HL From ASH 2023

Feat. S. Smith
10:02
Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "The Best of MPNs - Highlights & Key Take…

Feat. R. Mesa
21:52
Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "MF, ET, and PV - Highlights and Clinical Imp…

Feat. D. Tremblay
05:20
Prithviraj Bose

When to Switch From Hydroxyurea to Ruxolitinib in PV

29:26
Massachusetts General Hospital Cancer Center

Practice-Changing Updates in DLBCL and HL

Feat. J. Erika Haydu
15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay
17:21
Daniel Addison

Cardiovascular Considerations With (Contemporary) BTKi in the Treatm…

19:00
Indy Hematology Review

Waldenstrom’s Macroglobulinemia: Approaching the Newly Diagnosed and…

Feat. S. Treon
08:11
Krisstina Gowin

Counseling Patients With Newly Diagnosed PV or ET

09:27
ASH 2022 Conference Coverage

MAJIC-PV Trial: Ruxolitinib vs. Best Available Therapy for PV Intole…

Feat. M. McMullin